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Background: Patients with chronic whiplash-associated disorders (CWAD) are characterized by 
pain of traumatic origin, cognitive deficits, and central sensitization (CS). Previous neuroimaging 
studies revealed altered grey matter volume (GMV) in mild traumatic brain injury patients and 
chronic pain conditions also characterized by CS. It can therefore be hypothesized that GMV 
alterations also play a role in the persistent complaints of CWAD. However, brain alterations remain 
poorly investigated in these patients. 
Objectives: This study examined regional GMV alterations in patients with CWAD compared to 
patients with non-traumatic chronic idiopathic neck pain (CINP), who normally do not show CS 
at a group level, and healthy controls. Additionally, in both patient groups, relationships between 
regional GMV and measures of cognition as well as pain processing were assessed. 
Study Design: A cross-sectional case-control study.
Setting: This study was performed at the Department of Rehabilitation Sciences and Physiotherapy 
of Ghent University in cooperation with the Ghent Institute for Functional and Metabolic Imaging.
Methods: Ninety-three women (28 healthy controls, 34 CINP patients, and 31 CWAD patients) 
were enrolled. First, T1-weighted magnetic resonance images (MRIs) were acquired to examine 
GMV alterations in the brain regions involved in processing cognition and pain. Next, cognitive 
performance, pain cognitions, and CS symptoms were assessed. Finally, hyperalgesia and 
conditioned pain modulation efficacy were examined. 
Results: Regional GMV of the right lateral orbitofrontal cortex, left supramarginal cortex, and 
left posterior cingulate cortex was decreased in CWAD patients compared to healthy controls (P = 
0.023; P = 0.012; P = 0.047, respectively). Additionally, GMV of the right superior parietal cortex 
and left posterior cingulate cortex was decreased in CWAD patients compared to CINP patients 
(P = 0.008; P = 0.035, respectively). Decreased regional GMV correlated with worse cognitive 
performance, higher maladapted pain cognitions, CS symptoms, and hyperalgesia in CWAD 
patients (rs = -0.515 to -0.657; P < 0.01). In CINP patients, decreased regional GMV correlated 
only with worse cognitive performance (rs = -0.499 to -0.619; P < 0.01), and no GMV differences 
compared with the controls could be revealed. 
Limitations: No conclusions about the causality of the observed relationships can be drawn. 
Conclusions: These results provide the first evidence for reduced GMV in cortical regions 
involved in processing cognition and pain in patients with CWAD. Accordingly, it is recommended 
that therapy approaches for CWAD patients should address the brain and take into account 
neuroplasticity of the central nervous system (CNS).
Key words: Whiplash injuries, neck pain, magnetic resonance imaging, grey matter, cognitive 
dysfunction, pain catastrophizing, central sensitization 
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maladapt its morphology (18). Subsequently, the role 
of maladapted brain alterations, including GMV al-
terations (16-18), has been gradually elucidated in the 
persistent pain and associated complaints of various 
chronic pain conditions (e.g., fibromyalgia (19), chronic 
low back pain (20), temporomandibular disorders (21), 
chronic pelvic pain syndrome (22)). Especially, GMV 
alterations in the regions involved in cognitive process-
ing and sensory-discriminative, as well as affective and 
cognitive pain processing have been shown in various 
chronic pain syndromes, such as fibromyalgia and 
chronic low back pain, sharing the common pathophys-
iology of CS (19,20). For example, altered GM morphol-
ogy in the cingulate cortex, insular cortex, orbitofrontal 
cortex, precuneus, amygdala, and thalamus has been 
found in these patients. Furthermore, alterations in GM 
morphology are denoted to be related with persistent 
pain and cognitive symptoms (19-24), which are com-
monly reported complaints in these chronic pain condi-
tions (10,25-27). Moreover, these chronic pain patients 
often show maladapted pain cognitions including pain 
catastrophizing and hypervigilance (28), which seem to 
be associated with GM morphology (29). 
Research has furthermore demonstrated changes 
in GMV in patients with mild traumatic brain injury 
(TBI) (30), where chronic pain is also a common sequel 
(31,32). In addition, similar to patients with chronic 
pain, mild TBI patients frequently report persistent 
cognitive complaints (33) accompanied with reduced 
cognitive performance (34-36).
Based on the outlined evidence, due to the trauma, 
cognitive deficits (10), maladapted pain cognitions (11), 
and CS (12) in CWAD patients, it could be hypothesized 
that alterations in regional GMV are present in patients 
with CWAD, but not or to a lesser degree in patients 
with CINP. 
To address the current research gap, the first aim 
was to examine GMV alterations in the brain regions 
involved in cognitive processing and the regions impli-
cated in sensory-discriminative, affective, and cogni-
tive pain processing in patients with CINP and CWAD 
compared to healthy persons. The second aim was to 
investigate the relationships between regional GMV 
and cognitive deficits, pain intensity, pain cognitions, 
local hyperalgesia, and measures of CS in both of the 
chronic neck pain conditions. 
Distinct regional GMV alterations and significant 
relationships with measures of cognition, pain, and 
CS were mainly hypothesized in patients with CWAD 
compared to CINP patients and healthy persons. Ac-
Chronic neck pain is an enormous healthcare problem and one of the most prevalent musculoskeletal pain conditions worldwide 
(1,2). Furthermore, this pain condition is associated 
with unexplained symptoms, reduced quality of life, 
and poor therapy outcomes, thus representing an 
important source of disability (3-6). Chronic neck pain 
can be subdivided, on the basis of its etiology, into 3 
categories: specific neck pain, trauma-induced neck 
pain, and idiopathic (non-traumatic) neck pain. This 
article focuses on chronic neck pain of a traumatic and 
an idiopathic non-traumatic nature. 
Chronic whiplash-associated disorders (CWAD) 
are characterized by trauma-induced neck pain lasting 
more than 3 months resulting from a whiplash injury 
usually originating from a rear-end motor vehicle crash 
and caused by acceleration-deceleration forces acting 
on the neck, head, and torso (7,8). Chronic idiopathic 
non-traumatic neck pain (CINP) is characterized by neck 
pain lasting more than 3 months, without the presence 
of specific pathoanatomical causes. 
Based on a paucity of studies comparing patients 
with CINP and CWAD, indications for different underly-
ing mechanisms can be found (6,9). Cognitive deficits 
(10), maladapted pain cognitions (11), and central sen-
sitization (CS) (12) have been demonstrated in patients 
with CWAD. While CS is rare in patients with CINP (13), 
cognitive deficits and maladapted pain cognitions are 
present (6,14), however to a significantly lesser extent 
compared to patients with CWAD (6,13). 
Remarkably, although it can be hypothesized that 
structural brain alterations, including grey matter vol-
ume (GMV) alterations, play a role in the persistent and 
complex complaints of patients with CWAD, studies ex-
amining the presence of GM morphological alterations 
in patients with CWAD compared to patients with CINP 
are lacking. 
Examining the influence of the traumatic ac-
celeration-deceleration injury, the presence of GMV 
alterations, and exploring the relationships between 
regional GMV and measures of cognition, pain, and 
CS is important and could increase our insight into the 
underlying mechanisms of CINP and CWAD and their 
possible differences. 
During the past decades, a wide range of magnetic 
resonance imaging (MRI) techniques explored struc-
tural brain alterations in vivo in patients with chronic 
pain (15-17). This neuroimaging research has shown 
structural neuroplasticity, which refers to the ability 
of the brain to reorganize itself and thereby adapt or 
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cordingly, important differences between patients with 
CINP and CWAD were hypothesized with a negative 
mediating role of the trauma in CWAD patients.
Methods
Study Design and Procedure
This cross-sectional case-control study took place 
at the Department of Rehabilitation Sciences and 
Physiotherapy of Ghent University in cooperation with 
the Ghent Institute for Functional and Metabolic Imag-
ing. The study was performed from February 2014 to 
September 2015 and was carried out in accordance 
with the principles of the Declaration of Helsinki. The 
local Ethics Committee of the Ghent University Hospital 
(EC/2013/1053) approved the research protocol. All of 
the patients were thoroughly informed about the study 
procedures and signed an informed consent statement 
prior to study enrollment.  
First, all of the patients completed a survey to ac-
quire information on demographics and completed a 
series of questionnaires to obtain information on dis-
ability, pain intensity, pain cognitions, and CS symptoms 
(as described below). Subsequently, assessments to 
investigate cognitive deficits and pain processing were 
performed. On a separate test day (10 +/- 7 days apart), 
high-resolution T1-weighted MRIs and T2*-weighted 
images of the brain were acquired. 
Participants 
Ninety-three female patients (34 patients with 
CINP, 31 patients with CWAD, and 28 healthy, pain-free 
controls) were enrolled in the present study. In order to 
exclude the confounding factor of gender, we included 
only women, as research has demonstrated significant 
differences between men and women regarding GMV, 
pain sensitivity, and pain processing in both healthy per-
sons and pain patients (37-41). All of the patients were 
Dutch native speakers and 18 – 65 years old. The patients 
were recruited by calls on social media and through ad-
vertisements on the Ghent University website, in health 
magazines, and in an information brochure of an asso-
ciation for patients with whiplash. Furthermore, infor-
mative flyers and posters were distributed in different 
medical institutes and associations in Flanders (various 
hospitals, physical therapist practices, and medical phy-
sician practices). 
The inclusion criteria for patients with CINP and 
CWAD were persistent neck pain lasting more than 3 
months (42) with a mean pain intensity of more than 
3 of 10 on the numeric rating scale (NRS) during the 
preceding month. All chronic neck pain patients had to 
report mild/moderate to severe pain-related disability, 
established by a score of 10 or more of a maximum 
of 50 on the Neck Disability Index (43). Additionally, 
chronic neck pain patients had to report stability of 
pain medication intake for at least 4 weeks before 
study participation. 
A specific inclusion criterion for patients with CINP 
was persistent idiopathic (non-traumatic) neck pain. 
Patients with CINP were excluded if they ever experi-
enced a whiplash trauma or any other specific causes of 
neck pain, e.g., cervical hernia with clinical symptoms. 
Patients with CWAD were included only if they 
had neck pain resulting from a motor vehicle crash or 
traumatic event and classifiable as WAD II A, B, or C on 
the modified (44) Quebec Task Force Scale (45). Patients 
with CWAD grades I, III (neurological signs), or IV (frac-
ture or dislocation) on the modified Quebec Task Force 
Scale were excluded. Additionally, CWAD patients who 
lost consciousness as a result of the motor vehicle crash 
or traumatic event and patients who had suffered post-
traumatic amnesia were excluded (46).  
Healthy, pain-free women could participate only 
if they were pain-free on each test day (NRS score of 
< 2/10), had no history of neck-shoulder-arm pain for 
more than 8 consecutive days during the preceding 
year (with a pain intensity of 2 or more on the NRS), 
no medical consultation for neck-shoulder-arm pain 
during the preceding year, and no history of whiplash 
trauma. Additionally, healthy controls were included 
only if they had a score of less than 8 of 50 on the Neck 
Disability Index.
General exclusion criteria for all of the study 
groups were the presence of major depression, anxi-
ety, psychiatric, neurologic, metabolic, cardiovascular, 
and inflammatory disorders, fibromyalgia, chronic 
fatigue syndrome, and a history of neck or shoulder 
girdle surgery. Furthermore, all patients completed 
the MRI safety checklist and patients who presented 
contraindications for MRI were excluded. Finally, brain 
microhemorrhages related to a traumatic event were 
excluded based on visual inspection of T2*-weighted 
brain images. To preclude confounding factors, all of 
the patients were asked to discontinue intake of non-
opioid analgesics 48 hours before study participation. 
The continuation of intake of narcotic analgesics was 
allowed and the medication use of each patient was 
questioned in detail. In addition, the patients were 
asked to avoid heavy physical activities and to refrain 
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from consuming alcohol, caffeine, and nicotine on the 
day of testing. 
Self-Reported Pain and Disability Measures 
On each test day, the patients scored their current 
neck pain intensity on an 11-point verbal numeric rat-
ing scale (VNRS-11). The scores range from 0 to 10, with 
0 reflecting ‘no pain at all’ and 10 reflecting ‘the worst 
pain imaginable’. In addition, the patients reported 
the frequency of neck pain complaints in the number 
of days per week. The Dutch Neck Disability Index was 
used to investigate self-reported, pain-related dis-
ability levels (0 - 50) (43,47). Higher scores on the Neck 
Disability Index indicate higher levels of pain-related 
disability. The Dutch language version of the Neck Dis-
ability Index has been proven to be reliable and valid to 
assess self-reported disability in patients with chronic 
neck pain (48-50). 
Cognitive Performance
Subjective Cognitive Performance
The patients completed the Dutch modified Per-
ceived Deficits Questionnaire (mPDQ) to investigate 
subjective cognitive performance (0 - 72). This question-
naire investigates self-perceived cognitive problems 
in 4 different cognitive subdomains, i.e., prospective 
memory, retrospective memory, attention and concen-
tration, and organization and planning, during the 
preceding 4 weeks. Symptoms are rated on a 5-point 
Likert scale from never (0) to almost always (4). Higher 
scores represent more self-perceived cognitive deficits. 
The validity and reliability of the English mPDQ have 
been demonstrated in patients with CWAD and healthy 
persons (51). 
Objective Cognitive Performance
The Trail Making Test (TMT) was administered in 
order to objectively obtain an instrumented measure of 
cognitive performance (52). This test consists of 2 parts: 
trail A and trail B. The TMT part A requires mainly vi-
suoperceptual and processing speed abilities, whereas 
TMT part B reflects working memory and task-switch-
ing ability. In trail A, the patient was instructed to draw 
lines connecting 25 numbers in ascending order as fast 
as possible, without lifting the pencil from the page. 
In trail B, the patient had to draw lines alternating be-
tween numbers and letters in ascending order (going 
from 1 to A, from A to 2, etc.). The goal of the TMT 
was to finish part A and part B as quickly and as ac-
curate as possible. The researcher explained each part, 
and the patients completed a practice version contain-
ing fewer items. The time taken to complete each part 
of the test and a switch cost, calculated by subtracting 
the completion time of part A from part B, were used 
as outcome measures. The TMT (B-A) difference mini-
mizes visuoperceptual and working memory demands, 
thus providing an indication of executive function (52). 
Higher scores on completion time and switching cost 
denote worse cognitive performance. The TMT has 
been demonstrated to be valid for assessing cognitive 
deficits (52).
Self-Reported and Experimental Measures of 
Pain Processing
Pain Catastrophizing
The Dutch Pain Catastrophizing Scale (PCS) (0 - 52) 
was used to evaluate 3 components of catastrophizing: 
rumination, magnification, and helplessness (53). High-
er scores represent higher levels of pain catastrophiz-
ing. The Dutch PCS has sufficient test-retest reliability 
(54,55), and the factor structure is confirmed in chronic 
pain patients and healthy individuals (56). 
Pain Hypervigilance
The Dutch Pain Vigilance and Awareness Question-
naire (PVAQ) was administered to assess the level of 
vigilance towards pain (0 - 80). Higher scores indicate 
a higher degree of pain vigilance and awareness. 
The PVAQ has been shown to be valid and reliable to 
measure pain vigilance in healthy individuals (57) and 
chronic pain patients (58). 
Self-Reported Symptoms of CS
All of the patients completed the Dutch language 
version of the Central Sensitization Inventory (CSI). The 
CSI is a self-report screening instrument for the mea-
surement of clinical symptoms of CS (0 - 100) in chronic 
pain populations (59,60). Higher CSI scores denote a 
higher degree of CS symptoms. The Dutch CSI has been 
shown to have good internal consistency, excellent 
test-retest reliability, and good discriminative power 
to differentiate between healthy persons and chronic 
pain patients (59). Neblett et al (61) determined that 
a CSI score of 40 of 100 best distinguished between a 
group of CS syndrome patients (CSI scores ≥ 40/100) and 
a group of non-CS syndrome patients (sensitivity = 81%, 
specificity = 75%). 
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Local and Distant Hyperalgesia
The pressure pain thresholds (PPTs) were measured 
unilaterally with a digital pressure algometer with a 
1 cm2 tip (Wagner Instruments, FDX, Greenwich, Con-
necticut), both at a symptomatic local region (middle 
trapezius muscle midway between the spinous process 
of C7 and the lateral border of the acromion) to evalu-
ate local hyperalgesia and at a distant asymptomatic re-
gion (quadriceps muscle midway between the anterior 
superior iliac spine and the basis patellae) to evaluate 
widespread or distant hyperalgesia (62,63). The PPTs 
were assessed on the more painful side (64). In healthy 
women and when patients experienced the same 
amount of neck pain on both sides, PPTs were tested 
on the dominant handedness side. The PPTs were as-
sessed in a randomized order (with Research Random-
izer, https://randomizer.org). During the test procedure, 
the patients were seated and pressure was gradually 
increased at a rate of one kgf/s until the patients re-
ported the first sensation of unpleasantness. The PPT 
was determined as the mean of 2 consecutive measure-
ments, with 30 seconds in between. Decreased PPTs in 
the patient groups compared to the healthy controls at 
the middle trapezius muscle indicate local hyperalge-
sia, whereas decreased PPTs at the quadriceps muscle 
indicate distant hyperalgesia. This technique has been 
found to be reliable (65). In addition, the intratester re-
liability of PPT measurements has been reported to be 
satisfactory to good (intraclass correlation coefficient = 
0.78 – 0.93) (66). 
Efficacy of Conditioned Pain Modulation (CPM)
The presence of dysfunctional endogenous pain in-
hibition was investigated by evaluating the efficacy of 
CPM by applying a CPM paradigm. This paradigm relies 
on the “pain-inhibits-pain” mechanism, in which one 
noxious stimulus is used as a conditioning stimulus to 
induce a reduction in the perception of pain from an-
other test stimulus (67). The conditioning stimulus for 
eliciting CPM was the cold pressor test. The assessment 
of PPTs was used as the test stimulus. For the condition-
ing stimulus, the contralateral hand (of the PPT side) 
(68) was first immersed in water maintained at room 
temperature (22°C) for one minute to standardize the 
hand temperature (69) before immersing this hand 
(up to the wrist) in a refrigerated bath (VersaCool™, 
Thermo Fisher Scientific, Newington, NH) with circulat-
ing cold water maintained at 12 ± 1°C (70). The patients 
were asked to keep their hand in the water bath for 
2 minutes (69). Meanwhile, the PPT was re-evaluated 
at the quadriceps muscle, 45 seconds after immersing 
the hand (again twice with an interval of 30 seconds) 
(71). If the patients removed the hand from the water 
before the end of the 2 minutes, the measurement was 
registered as missing. For analysis of CPM efficacy, the 
mean PPT measured before the cold pressor test was 
subtracted from the mean PPT measured during the 
cold pressor test. Hence, a lower CPM value reflected 
less efficient endogenous pain inhibition. The intrases-
sion and intraclass correlation coefficients for the cold 
pressor test have been shown to be excellent (0.85) (71). 
MRI Data Acquisition
MRIs were acquired on a 3T Siemens Magnetom 
TrioTim MRI scanner (Siemens, Erlangen, Germany) 
equipped with a 32-channel matrix head coil, at the 
Ghent University Hospital. High-resolution T1-weighted 
images of the brain were acquired using a 3-dimension-
al magnetization prepared rapid acquisition gradient 
echo (MP-RAGE) (repetition time [TR] = 2250 ms, echo 
time [TE] = 4.18 ms, voxel size = 1 x 1 x 1 mm3, FoV = 256 
mm, flip angle = 9°, 176 slices, one mm slice thickness, 
and acquisition time = 5’14’’). All T1-weighted anatomi-
cal scans were visually checked for overall quality and 
motion artifacts. 
In addition, axial T2*-weighted brain images were 
acquired using a T2*-weighted acquisition gradient 
echo with TR = 839 ms, TE = 18.60 ms, voxel size = 1 
x 0.7 x 3 mm3, FoV = 230 mm, flip angle = 20°, 3 mm 
slice thickness, and acquisition time of 3’48”. All T2*-
weighted images were visually inspected by 2 expert 
neuroradiologists (KD, EG) to evaluate and exclude pos-
sible microhemorrhages related to a traumatic event.
MRI Data Processing 
The high-resolution T1-weighted anatomical scans 
were analyzed utilizing the FreeSurfer v5.3.0 software 
package, which is documented and freely available 
(http://surfer.nmr.mgh.harvard.edu). The analyses were 
performed utilizing additional computing resources 
from the high-performance computing TIER1 cluster 
at the University of Ghent (www.ugent.be/hpc/). The 
FreeSurfer analysis suite was used to extract cortical 
and subcortical GMVs using an automated approach 
described in detail in prior publications (for an over-
view see Fischl 2012 (72)). Previous research has shown 
that this automated procedure yields accurate and reli-
able results (73). Briefly, image processing included: (1) 
removal of non-brain tissue using a hybrid watershed/
surface deformation procedure (skull stripping) (74), (2) 
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automated Talairach transformations, (3) segmentation 
of the subcortical white matter and deep GM volumet-
ric structures (73,75), (4) intensity normalization (76), 
(5) tessellation of the boundary between GM and white 
matter, automated topology correction (77,78), and (6) 
surface deformation along intensity gradients for opti-
mal placement of the borders between GM, white mat-
ter, and cerebrospinal fluid (79-81). Automated parcel-
lation of the cerebral cortex into units with respect to 
gyral and sulcul structures was performed within each 
hemisphere using the Desikan atlas (82). Furthermore, 
an automated segmentation (Aseg) of subcortical GM 
regions within each hemisphere was performed in Free-
Surfer (73,75). Also, an estimate of the total intracranial 
volume was obtained for each patient. 
Two independent researchers (IC, RDP) visually 
checked the data quality of the FreeSurfer processing 
output including the accuracy of skull stripping, regis-
tration, segmentation, and cortical surface reconstruc-
tion. Poor data quality, such as inclusion of dura in the 
pial surface after skull stripping and surface deforma-
tions, was revealed in 12 patients (healthy controls = 3, 
CINP = 3, and CWAD = 6). These datasets were excluded 
from all further analyses. All other data were of good 
quality and were used for further analyses. 
Regions of Interest
GMV was extracted from regions of interest (ROIs). 
Cortical and subcortical regions, which have been re-
ported to be involved in processing pain and cognition 
in previous studies, were selected as ROIs. Furthermore, 
ROIs were defined based on observations from previous 
studies in patients with chronic pain regarding GMV 
alterations (15,19,20,83) and regarding relationships 
between GMV alterations and measures of cognition 
and pain (15,84-86). The ROIs constituting pain and 
cognitive processing regions included 2 subcortical 
GM structures: amygdala and thalamus (see Fig. 1 for 
subcortical ROIs) and 12 cortical regions selected from 
the Desikan atlas (82): caudal anterior cingulate, rostral 
anterior cingulate, posterior cingulate, rostral middle 
frontal, medial orbitofrontal, lateral orbitofrontal, 
superior parietal, insula, postcentral, precuneus, pars 
orbitalis, and supramarginal cortex (see Fig. 1 for cor-
tical ROIs). For each ROI, GMV was calculated for the 
right and left hemisphere separately. In addition, the 
volumes of total subcortical GM and total cortical GM 
were obtained. 
Statistical Analyses
All statistical analyses were performed with SPSS 
Statistics 22.0 (IBM Corporation, Armonk, NY). First, the 
normality of variables was checked with the Shapiro-
Wilk test and by visual evaluation of quantile-quantile 
plots and histograms. Additionally, the equality of 
variance was examined with the Levene’s test. Only 
normally distributed data with an equality of variance 
were analyzed with parametric tests. Otherwise, non-
parametric tests were applied.
The comparability of the study groups for age, cur-
Fig. 1. Lateral (left fig.) and medial (center fig.) view of  the cortical parcellation of  the Desikan atlas (82) displayed on an 
inflated template (https://surfer.nmr.mgh.harvard.edu). Numbered regions indicate the cortical regions of  interest: 1) rostral 
middle frontal, 2) lateral orbitofrontal, 3) pars orbitalis, 4) insula, 5) postcentral, 6) superior parietal, 7) supramarginal, 8) 
precuneus, 9) posterior cingulate, 10) caudal anterior cingulate, 11) rostral anterior cingulate, and 12) medial orbitofrontal. 
View (right fig.) of  the subcortical parcellation of  the Aseg atlas (73) (https://surfer.nmr.mgh.harvard.edu). Numbered regions 
indicate the subcortical regions of  interest: 13) thalamus and 14) amygdala.
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rent neck pain intensity, pain duration, and other de-
mographics was explored with a one-way ANOVA with 
post-hoc pairwise comparisons using Bonferroni correc-
tion (family-wise error rate (FWER) < 0.05) or with the 
Kruskal-Wallis test with post-hoc pairwise comparisons 
using the Mann-Whitney U test. Differences measured 
with the Mann-Whitney U test were assumed to be 
significant only below the 0.017 (Bonferroni correction: 
0.05/3) level. Categorical data were analyzed with the 
Fisher’s exact test. 
Subsequently, differences between the study 
groups regarding cognitive performance and pain 
processing were explored using one-way ANOVA (post-
hoc pairwise comparisons using Bonferroni correction, 
FWER < 0.05) or the Kruskal-Wallis test (post-hoc pair-
wise comparisons using the Mann-Whitney U test, P 
< 0.017). An analysis of covariance (ANCOVA) model, 
controlling for the potentially confounding factor of 
age, was used to determine significant group differ-
ences in GMV of the selected ROIs and total subcortical 
and cortical GMV (post-hoc pairwise comparisons using 
Bonferroni correction, FWER < 0.05).
Finally, correlations among measures of cogni-
tion and pain on one hand and regional GMV on the 
other hand in both chronic neck pain conditions were 
investigated with group-specific Spearman correla-
tion analyses. To correct for multiple comparisons, we 
deemed only Spearman correlations below the 0.01 
level (2-tailed) to be significant. Correlation coefficients 
were deemed low between 0.30 to 0.50, moderate be-
tween 0.50 to 0.70, high between 0.70 to 0.90, and very 
high between 0.90 to 1.00 (87).
Results
Differences Between Patients with Idiopathic 
and Traumatic Chronic Neck Pain Compared 
to Healthy Controls
Demographic Characteristics and Self-Reported 
Pain and Disability Measures
The results of demographic characteristics and 
self-reported pain and disability measures of 81 women 
(25 healthy controls, 31 patients with CINP, and 25 
patients with CWAD) are shown in Table 1. All of the 
study groups were comparable in age, body height, 
body weight, body mass index, education level, smok-
ing status, menstrual phase, and handedness (P > 0.05). 
Furthermore, both of the groups with chronic neck pain 
were comparable in medication use, neck pain dura-
tion, and frequency of neck pain complaints per week 
(P > 0.05). Patients with CWAD reported significantly 
higher current neck pain intensity on the clinical and 
MRI test day and significantly more pain-related dis-
ability than patients with CINP (P < 0.01). 
Ninety-one percent of all patients were right-hand-
ed. This is a representative sample regarding handed-
ness because approximately 10 percent of the general 
population is ambidextrous or left-handed (88). The 
ANCOVA, with age as the covariate and handedness as 
the fixed-factor, revealed no significant main effect of 
handedness on total and regional GMV. Therefore, the 
GMV results of the left- and right-handed women were 
analyzed together.
Cognitive Performance
Subjective Cognitive Performance
Compared with the healthy controls, patients with 
CINP (P = 0.009) and patients with CWAD (P < 0.001) 
reported more self-perceived cognitive deficits, as pre-
sented in Table 1. Moreover, CWAD patients reported 
more self-perceived cognitive deficits compared to 
patients with CINP (P = 0.001). 
Objective Cognitive Performance
The time needed to perform TMT part A (P = 0.002) 
and TMT part B (P = 0.004) was significantly longer 
in the CWAD group compared to the healthy control 
group, denoting worse objective cognitive performance 
in patients with CWAD (Table 1). In addition, the time 
needed to perform TMT part A (P = 0.003) and TMT part 
B (P = 0.009) was significantly longer in CWAD patients 
compared to CINP patients. Despite the differences in 
completion time, no significant group differences were 
revealed for executive control or switching cost (TMT 
(B-A) difference), (P’s > 0.05). 
Self-Reported and Experimental Measures of Pain 
Processing
Pain Catastrophizing and Pain Hypervigilance
As shown in Table 1, maladapted pain cognitions, 
including pain catastrophizing and hypervigilance, were 
significantly higher in patients with CWAD compared 
to healthy women (P = 0.003; P = 0.035, respectively). 
No significant differences between CINP patients and 
healthy controls were found regarding pain catastroph-
izing and pain hypervigilance (P > 0.05).
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Mean Median SD
Range
(min-max)
IQR
Test 
Statistic 
(P-Value)
P-Value 
Post-
Hoc
Demographic 
Characteristics
Age (yrs)a
HCON 30.32 24.00 13.20 18.00 – 62.00 22.50 – 36.50
5.393 
(0.067) N/ACINP 34.93 34.00 10.85 18.00 – 54.00 26.00  – 45.00
CWAD 35.32 35.00 10.83 21.00 – 58.00 25.00 – 43.50
Body Height (cm)b
HCON 167.16 167.00 6.01 155.00 – 178.00 163.00 – 170.00
0.044 
(0.957) N/ACINP 166.76 168.00 5.28 157.00 – 175.00 163.00 – 170.50
CWAD 167.12 166.00 5.38 155.00 – 176.00 163.50 – 172.00
Body Weight (kg)a
HCON 60.87 59.00 7.29 51.00 – 81.00 55.35 – 65.00
1.500 
(0.472) N/ACINP 63.38 60.50 9.02 50.00 – 86.00 56.75 – 69.25
CWAD 62.02 60.00 12.67 48.00 – 95.00 51.00 – 67.50
Body Mass Index (kg/
m2)a,†
HCON 21.76 21.80 2.07 18.07 – 26.75 20.45 – 23.06
1.742 
(0.418) N/ACINP 22.64 22.74 2.68 18.65 – 29.07 20.31 – 24.45
CWAD 22.17 21.14 4.18 16.65 – 32.05 19.14 – 23.59
Frequencies
Education Level n (%)c
No degree; lower 
second.; higher second.; 
higher edu.
HCON 0 (0); 1 (4); 6 (24); 18 (72)
0.782 
(0.991) N/A
CINP 0 (0); 2 (6.5); 7 (22.6); 20 (64.5)
CWAD 0 (0); 1 (4); 5 (20); 19 (76)
Smoker n (%)c
Smoker; former 
smoker; non-smoker
HCON 1 (4); 3 (12); 21 (84)
4.801 
(0.299) N/ACINP 1 (3.2); 9 (29); 18 (58.1)
CWAD 3 (12); 6 (24); 16 (64)
Menstrual Phase 
Clinical Test Day n 
(%)c
Follicular phase (day 
one to 13); ovulation 
phase (day 14); luteal 
phase (day 15 to 28);  
peri menopause;  post-
menopause; no menses 
(intrauterine device, 
taking pill ceaseless)
HCON 14 (56); 2 (8); 4 (16); 1 (4); 2 (8); 1 (4)
10.374 
(0.344) N/A
CINP 16 (51.6); 1 (3.2); 6 (19.4); 1 (3.2); 4 (12.9); 1 (3.2)
CWAD 8 (33.3); 0 (0); 9 (37.5); 0 (0); 3 (12.5); 4 (16.7)
Handedness n (%)c
(LH; RH)
HCON 2 (8) ; 23 (92)
0.691 
(0.884) N/ACINP 2 (6.5); 29 (93.5)
CWAD 3 (12) ; 22 (88)
Demographic 
Characteristics: 
Medication Use
Analgesics - 
Antipyretics n (%)c
HCON 0 (0)
2.970 
(0.158) N/ACINP 3 (9.7)
CWAD 7 (28)
Narcotic Analgesics 
n (%)c
HCON 0 (0)
1.222 
(0.455) N/ACINP 0 (0)
CWAD 1 (4)
Benzodiazepines n (%)c
HCON 0 (0)
3.897 
(0.082) N/ACINP 1 (3.20)
CWAD 5 (20)
Antidepressants n (%)c
HCON 0 (0)
0.849 
(1.000) N/ACINP 3 (9.70)
CWAD 1 (4)
Table 1. Demographic characteristics, self-reported pain and disability measures, maladaptive pain cognitions, self-reported symptoms 
of  CS, subjective and objective cognitive performance, local and distant hyperalgesia, and conditioned pain modulation efficacy.
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Mean Median SD
Range
(min-max)
IQR
Test 
Statistic 
(P-Value)
P-Value 
Post-
Hoc
Self-Reported 
Pain  Measures
Neck Pain Duration 
(mos)a
HCON N/A N/A N/A N/A N/A
0.076 
(0.783) N/ACINP 92.96 60.00 88.21 4.00 – 30.00 24.00 – 138.00
CWAD 86.87 51.50 96.13 6.00 – 44.00 26.25 – 115.00
Days/wk Neck Paina
HCON N/A N/A N/A N/A N/A
3.048 
(0.081) N/ACINP 5.14 5.00 1.61 3.00 – 7.00 4.00 – 7.00
CWAD 5.95 7.00 1.70 2.00 – 7.00 5.00 – 7.00
Current Neck 
Pain Intensity 
(VNRS/10)_Ca,†
HCON 0.08 0.08 0.28 0.00 – 1.00 -0.03  – 0.19
44.391
(< 0.001)
< 0.001d
< 0.001e
< 0.011f
CINP 3.85 3.85 2.57 0.00 – 8.00 2.91  – 4.80
CWAD 5.76 5.76 2.65 0.00 – 10.00 4.67  – 6.85
Current Neck 
Pain Intensity 
(VNRS/10)_Ma,†
HCON 0.00 0.00 0.00 0.00 – 0.00 0.00 – 0.00
72.467
(< 0.001)
< 0.001d
< 0.001e
< 0.001f
CINP 3.43 3.43 1.98 0.00 – 7.00 2.71 – 4.16
CWAD 5.98 5.98 2.28 1.00 – 10.00 5.04 – 6.92
Self-Reported 
Disability
Neck Disability Index 
(/50)a,†
HCON 2.76 2.00 1.61 1.00 – 6.00 1.00 – 4.00
54.439
(< 0.001)
< 0.001d
< 0.001e
0.001f
CINP 16.36 16.00 5.03 10.00 – 27.00 12.00 – 20.50
CWAD 23.04 23.00 6.93 10.00 – 37.00 18.00 – 27.50
Subjective 
Cognitive 
Performance
mPDQ Total (/72)a,†
HCON 11.52 10.00 7.00 1.00 – 25.00 6.00 – 16.00
26.448
(< 0.001)
0.009d
< 0.001e
0.001f
CINP 18.85 14.00 10.34 5.00 – 44.00 11.00 – 22.00
CWAD 31.83 28.50 14.61 6.00 – 57.00 19.00 – 46.50
Objective 
Cognitive 
Performance 
(TMT)
TMT Part A (sec)a,†
HCON 19.11 18.76 3.83 12.28 – 29.75 16.22 – 21.83
12.757 
(0.002)
0.586d
0.002e
0.003f
CINP 19.80 19.37 4.29 11.56 – 30.13 16.86 – 22.41
CWAD 29.00 27.09 14.27 15.06 – 81.00 18.95 – 31.82
TMT Part B (sec)a,†
HCON 41.86 34.37 24.02 21.44 – 128.00 27.86 – 45.89
10.747 
(0.005)
0.317d
0.004e
0.009f
CINP 42.73 37.00 23.38 26.6 – 148.00 31.05 – 44.36
CWAD 66.02 44.83 48.62 27.93 – 251.00 37.13 – 79.50
TMT (B-A)a,†
HCON 22.75 16.46 21.60 2.25 – 98.25 11.64 – 24.61
2.333 
(0.311) N/ACINP 22.93 17.83 21.09 7.08 – 121.02 13.78 – 24.07
CWAD 37.02 20.93 37.83 5.85 – 170.00 13.28 – 57.65
Maladaptive 
Pain 
Cognitions
Pain Catastrophizing 
(/52)b
HCON 9.76 10.00 8.61 0.00 – 30.00 1.00 – 18.00
9.740 
(0.004)
0.308d
0.003e
0.166f
CINP 13.65 13.00 7.19 1.00 – 26.00 6.00 – 19.50
CWAD 18.24 19.00 10.09 0.00 – 37.00 10.00 – 27.50
Pain Hypervigilance 
(/80)b
HCON 30.24 32.00 10.88 10.00 – 55.00 20.50 – 39.00
6.560 
(0.026)
0.096d
0.035e
1.000f
CINP 36.97 37.00 12.36 16.00 – 70.00 29.50 – 46.00
CWAD 38.48 38.00 10.28 16.00 – 56.00 30.00 – 46.50
Self-Reported 
Symptoms 
of CS
CS Inventory (/100)a,†
HCON 20.25 20.00 6.42 9.00 – 35.00 16.00 – 23.00
44.731
(< 0.001)
< 0.001d
< 0.001e
0.005f
CINP 40.48 40.00 10.02 22.00 – 68.00 35.00 – 47.50
CWAD 49.33 48.50 13.82 13.00 – 67.00 41.00 – 63.25
Local HA PPT Trapezius (kgf)a
HCON 4.42 3.69 1.90 1.86 – 9.81 3.27 – 5.75
12.295 
(0.002)
0.009d
0.001e
0.299f
CINP 3.24 2.76 1.69 1.18 – 7.43 2.01 – 4.04
CWAD 2.81 2.46 2.01 0.13 – 9.30 1.68 – 3.41
Distant HA PPT Quadriceps (kgf)b
HCON 4.95 4,38 1.57 2.94 – 8.40 3.71 – 6.16
4.768 
(0.011)
0.262d
0.008e
0.401f
CINP 4.09 3.47 2.03 1.45 – 9.72 2.54 – 5.68
CWAD 3.34 3.15 1.87 0.30 – 7.72 1.95 – 4.74
Table 1 (cont.). Demographic characteristics, self-reported pain and disability measures, maladaptive pain cognitions, self-reported symptoms 
of  CS, subjective and objective cognitive performance, local and distant hyperalgesia, and conditioned pain modulation efficacy.
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Self-Reported CS Symptoms
Both of the patient groups reported significantly 
more self-perceived CS symptoms compared to healthy 
pain-free women (P < 0.001) (Table 1). Moreover, pa-
tients with CWAD experienced significantly more CS 
symptoms compared to patients with CINP (P = 0.005).
Local and Distant Hyperalgesia
Decreased PPTs were demonstrated at the middle 
trapezius muscle and quadriceps muscle in patients 
with CWAD (P = 0.001, P = 0.008, respectively) but were 
found only at the middle trapezius muscle in patients 
with CINP, relative to the results for healthy women (P 
= 0.009) (Table 1). 
Efficacy of Conditioned Pain Modulation
The CPM value measured at the quadriceps muscle 
was significantly lower in patients with CWAD com-
pared to healthy women (P = 0.010), as presented in 
Table 1. 
Total Cortical and Subcortical GMV 
As shown in supplementary Table A, the ANCOVA 
with age as the covariate revealed no significant differ-
ences between all of the study groups for total intracra-
nial volume (P = 0.109), total cortical GMV (P = 0.198), 
and total subcortical GMV (P = 0.510). Therefore, we 
decided not to include these metrics in further analyses.
Regional-Based GMV 
The significant results of the ANCOVA with age 
as the covariate, investigating the differences in GMV 
of pain and cognitive processing regions between pa-
tients with CINP and CWAD and healthy controls, are 
presented in Fig. 2 and supplementary Table A. The 
non-significant ANCOVA results for GMV of the ROIs 
are shown in supplementary Table B.
The ANCOVA revealed decreased GMV in the left 
posterior cingulate cortex (P = 0.047), the right lateral or-
bitofrontal cortex (P = 0.023), and the left supramarginal 
cortex (P = 0.012) in patients with CWAD compared to 
healthy controls (Bonferroni-adjusted P-values). Further-
more, decreased GMV in the left posterior cingulate cor-
tex (P = 0.035) and the right superior parietal cortex (P = 
0.008) in CWAD patients compared to CINP patients was 
demonstrated with the ANCOVA (Bonferroni-adjusted P-
values). No significant differences in regional GMV were 
found between patients with CINP and healthy women 
(P’s > 0.05). In addition, no significant subcortical GMV 
differences were found in the amygdala and thalamus 
between all of the study groups (P > 0.05). 
Mean Median SD
Range
(min-max)
IQR
Test 
Statistic 
(P-Value)
P-Value 
Post-
Hoc
CPM Efficacy
CPM Quadriceps
(PPT quadriceps 
during CPT minus 
PPT quadriceps before 
CPT)b
HCON 1.19 1.31 0.70 -0.14 – 3.00 0.68 – 1.51
4.978 
(0.010)
1.000d
0.010e
0.054f
CINP 1.04 0.90 1.02 -0.59 – 3.29 0.41 – 1.66
CWAD 0.45 0.37 0.68 -0.75 – 1.87 -0.08 – 1.02
The distribution of the continuous data within each group was assessed by histograms, QQ-plots, and the Shapiro-Wilk test. 
aData which were not normally distributed, and subsequently group differences were analyzed using the Kruskal-Wallis test, and for post-hoc pair-
wise comparisons the Mann-Whitney U test. Shapiro-Wilk test P < 0.05 and visual inspection of the QQ-plot and histogram within each group 
provided information that the data were not normally distributed. To correct for multiple comparisons, differences measured with the Mann-
Whitney U test were only deemed significant below the 0.017 level (Bonferonni correction: 0.05/3). bData which were assumed to be normally 
distributed and variances were equally distributed across groups were analyzed with one-way ANOVA (F-test) and post-hoc pairwise comparisons 
were applied using Bonferroni correction (P < 0.05). cCategorical data were analyzed by performing the Fisher’s exact test. Significant differences 
were presented in bold. †Variances were not equally distributed across the groups, Levene’s test P < 0.05, dP-value for significant differences be-
tween CON-CINP, eP-value for significant differences between CON-CWAD, fP-value for significant differences between CINP-CWAD. There 
were 3 absences (1 HCON, 2 CINP) for the menstrual phase. Abbreviations: CON = healthy, pain-free controls, CWAD = chronic whiplash-associ-
ated disorders, CINP = chronic idiopathic neck pain, VNRS = verbal numeric rating scale, SF-36 = Short Form Health Survey, No degr = no de-
gree, Lower second = lower secondary, Higher second = higher secondary, Higher edu = higher education, HA = hyperalgesia, CPM = conditioned 
pain modulation, CPT = cold pressor test, mPDQ = modified perceived deficits questionnaire, TMT = trail making test, CS = central sensitization, 
kgf = kilogram force, PPT = pressure pain thresholds, VNRS = verbal numeric rating scale, IQR = interquartile range. Data of 81 patients were 
analyzed (25 healthy controls, 31 CINP patients, and 25 CWAD patients).
Table 1 (cont.). Demographic characteristics, self-reported pain and disability measures, maladaptive pain cognitions, self-reported 
symptoms of  CS, subjective and objective cognitive performance, local and distant hyperalgesia, and conditioned pain modulation 
efficacy.
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Fig. 2. Regional GMV decrease in patients with CWAD compared to CINP patients and healthy women. Abbreviations: HCON 
= healthy, pain-free controls, CINP = chronic idiopathic neck pain, CWAD = chronic whiplash-associated disorders, SE = 
standard error. Data were analyzed using ANCOVA with age as the covariate, and post-hoc pairwise comparisons were applied 
using Bonferroni correction.* = P < 0.05, ** = P < 0.01.
Relationships Between Regional GMV and 
Cognitive Deficits, Pain Intensity, and Pain 
Processing in Patients with Idiopathic and 
Traumatic Chronic Neck Pain 
CINP
The results of the Spearman correlation (rs) analy-
ses between GMV of regions involved in pain and cog-
nitive processing and cognitive deficits, pain intensity, 
and pain processing in patients with CINP are shown in 
Tables 2a and 2b.
In the CINP group, only 4 significant correlations 
were revealed. A moderate relationship was found 
between increased severity of self-reported cognitive 
deficits and decreased GMV of the left rostral anterior 
cingulate cortex (rs = -.499; P = 0.008). Furthermore, 
lower visuoperceptual abilities were moderately cor-
related with decreased GMV of the right thalamus (rs= 
-0.529; P = 0.003). Also, decreased task-switching capac-
ity was moderately correlated with decreased GMV 
of the left medial orbitofrontal cortex (rs = -.565; P = 
0.001). A moderate relationship was observed between 
decreased GMV of the left medial orbitofrontal cortex 
and worse executive control (rs = -.619; P < 0.001).
No significant correlations among pain intensity, 
maladapted pain cognitions, CS symptoms, experimen-
tal measures of pain processing, and regional GMV 
were demonstrated (P > 0.01). 
CWAD
The results of the Spearman correlation (rs) analyses 
between GMV of regions involved in pain and cognitive 
processing and cognitive deficits, pain intensity, and 
pain processing in patients with CWAD are displayed in 
Tables 3a and 3b. 
In the CWAD group, more robust correlations 
were found compared to the CINP group. Moderate 
correlations were revealed between increased severity 
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of self-reported cognitive deficits and decreased GMV 
of the left pars orbitalis (rs = -.543; P = 0.006), the left 
amygdala (rs = -0.598; P = 0.002), and the right medial 
orbitofrontal cortex (rs = -0.548; P = 0.006). Further-
more, decreased task-switching capacity was moderate-
ly correlated with decreased GMV of the right rostral 
anterior cingulate cortex (rs = -.588; P = 0.002), the right 
posterior cingulate cortex (rs = -0.538; P = 0.007), the 
left rostral middle frontal cortex (rs = -0.604; P = 0.002), 
and the left insula (rs = -0.539; P = 0.007). In addition, 
worse executive control was moderately correlated 
with decreased GMV of the left rostral middle frontal 
cortex (rs= -0.617, P = 0.001), the left lateral orbitofron-
tal cortex (rs = -0.539, P = 0.007), the left insula (rs = 
-0.634, P = 0.001), the right posterior cingulate cortex (rs 
= -0.594, P = 0.002), and the right lateral orbitofrontal 
cortex (rs = -0.569, P = 0.004). 
Moderate correlations were demonstrated be-
tween higher levels of pain catastrophizing and 
decreased GMV of the left precuneus (rs = -0.522; P = 
0.007), the left pars orbitalis (rs = -0.560; P = 0.004), the 
right medial orbitofrontal cortex (rs = -0.535; P = 0.006), 
and the right insula (rs = -0.515; P = 0.008). Furthermore, 
moderate correlations were found between higher 
levels of pain hypervigilance and decreased GMV of 
the left rostral middle frontal cortex (rs = -0.576; P = 
0.003), the left thalamus (rs = -0.572; P = 0.003), and the 
right posterior cingulate cortex (rs = -0.657; P < 0.001). 
A moderate relationship was observed between more 
self-perceived CS symptoms and decreased GMV of the 
left amygdala (rs = -0.636; P = 0.001). 
Moreover, a moderate relationship was found be-
tween lower PPTs at the trapezius muscle and decreased 
GMV of the left postcentral cortex (rs = 0.551; P = 0.004). 
Finally, no significant correlations were detected be-
tween regional GMV and the efficacy of CPM (P > 0.01).
discussion
The results of the present innovative study provided 
evidence for decreased GMV in cortical regions known 
to be associated with processing cognition and pain in 
patients with CWAD compared to CINP patients and 
healthy persons. In contrast, regional GMV alterations 
were not observed in CINP patients compared to healthy 
persons. Furthermore, this study revealed for the first 
time that increased cognitive deficits, maladapted pain 
cognitions, CS symptoms, and local hyperalgesia were 
moderately correlated with decreased regional GMV 
in CWAD patients. In CINP patients, regional GMV was 
only correlated with cognitive deficits. 
Group Differences in Regional GMV
The observed cortical GMV decrease in patients 
with CWAD compared to CINP patients and healthy 
controls was in line with our hypothesis and could be 
explained because CWAD patients have a traumatic ori-
gin of neck pain and are characterized by CS in contrast 
to CINP patients, who have a non-traumatic origin of 
neck pain and do not show CS at a group level. In the 
present study, decreased GMV was demonstrated in the 
left posterior cingulate cortex and the right superior 
parietal cortex in patients with CWAD compared to 
CINP. This is the first study investigating and reveal-
ing these regional GMV differences between women 
with CINP and CWAD. Compared to healthy women, 
decreased GMV could also be revealed in the left poste-
rior cingulate cortex, right lateral orbitofrontal cortex, 
and left supramarginal cortex in women with CWAD. 
These findings are in line with accumulating evidence 
of decreased regional GMV in other chronic pain popu-
lations characterized by CS, such as fibromyalgia and 
chronic low back pain (19-21,89,90). In particular, de-
creased GMV has previously been observed in the pos-
terior cingulate cortex, lateral orbitofrontal cortex, and 
supramarginal cortex in the latter chronic pain popula-
tions compared to healthy persons (19,20,83,91-94).
One previous study of patients who developed 
chronic headache after a whiplash injury also observed 
regional GMV decrease, however in the anterior cingu-
late cortex and the dorsolateral prefrontal cortex in the 
patient group compared to healthy controls (95). To our 
knowledge, only one previous study has examined GMV 
alterations in patients with non-traumatic chronic neck 
pain, more specifically in patients with chronic myo-
fascial pain resulting from active trigger points in the 
trapezius muscle. The authors found decreased GMV in 
the left parahippocampal cortex, and the right fusiform 
cortex in the patient group compared to healthy per-
sons (96). Despite these promising results, the authors 
did not correct for multiple comparisons. 
Nevertheless, contrary to previous evidence regard-
ing GMV alterations in regions such as the insula, anteri-
or cingulate cortex, and amygdala in other chronic pain 
patients, we could not find GMV alterations in all other 
ROIs. Although, this can be due to methodological fac-
tors (e.g., MRI acquisition parameters, MRI processing, 
poor control in previous studies for age, pain duration, 
and comorbidities (97)); unique pathology-specific GM 
morphology alterations in different chronic pain types 
(85,91) may also account for these differences. 
On the basis of the results of a quantitative meta-
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analysis investigating GMV alterations in patients with 
chronic pain, the observed estimated mean differences 
in regional GMV (mm3) of the present study in patients 
with CWAD compared to healthy controls are rather com-
parable with the results of GMV changes in other chronic 
pain patients (83). However, caution is warranted when 
comparing the results of studies that applied different 
MRI acquisition, analyzing, and processing techniques 
(e.g., FreeSurfer versus voxel-based morphometry). 
Group Differences in Measures of Cognition, 
Pain, and CS
Furthermore, patients with CWAD displayed higher 
neck pain intensity, more severe pain-related disability, 
more pronounced cognitive deficits, and more signs of 
CS compared to patients with non-traumatic CINP. One 
previous study comparing CINP and CWAD patients also 
observed significant features of CS in CWAD patients 
and not in patients with CINP (98). Moreover, higher 
levels of pain catastrophizing and hypervigilance were 
only present in the CWAD group compared to healthy 
persons. Accordingly, based on the present study re-
sults, it is plausible that more severe cognitive deficits 
and disturbed pain processing in CWAD patients are 
associated with a larger extent of maladapted GM 
morphology reorganization compared to patients with 
CINP. 
Relationships Between Regional GMV and 
Measures of Cognition, Pain, and CS
The results of our correlation analyses have dem-
onstrated relationships between decreased regional 
GMV and debilitating symptoms in CWAD patients. In 
particular, we revealed that decreased GMV in cogni-
tive and pain processing regions (left pars orbitalis, left 
amygdala, left rostral middle frontal cortex, lateral or-
bitofrontal cortex bilateral, insula bilateral, left precu-
neus, left thalamus, left postcentral cortex, right medial 
orbitofrontal cortex, right rostral anterior cingulate 
cortex, and right posterior cingulate cortex) coincided 
with increased cognitive deficits, maladapted pain cog-
nitions, CS symptoms, and local hyperalgesia in CWAD. 
Noteworthy, in CINP patients, decreased GMV (left ros-
tral anterior cingulate cortex, left medial orbitofrontal 
cortex, and right thalamus) was only associated with in-
creased cognitive deficits but not with pain cognitions, 
CS symptoms, and local hyperalgesia. The present study 
could not detect relationships between CPM efficacy 
and regional GMV in both chronic neck pain groups 
in contrast to a previous morphological MRI study in 
patients with irritable bowel syndrome (99). This study 
revealed a relationship between endogenous pain inhi-
bition and cortical thickness in the lateral orbitofrontal 
cortex. This inconsistent result could be, however, ex-
plained by a different CPM paradigm and a different 
macrostructural metric (cortical thickness versus GMV) 
(99). 
Remarkably, only GMV of the right lateral orbi-
tofrontal cortex was sensitive in detecting significant 
group differences and was also correlated with mea-
sures of cognition and pain. Specifically, decreased 
GMV in the right lateral orbitofrontal cortex in CWAD 
patients correlated with worse executive control. 
Functional neuroimaging combined with neuropsycho-
logical data have provided evidence which indicates an 
important role of the orbitofrontal cortex in decision-
making (100) and executive control of information 
processing by inhibiting neural activity associated with 
painful sensations (101). 
Furthermore, the present study showed associa-
tions between increased self-reported cognitive deficits 
and worse objective cognitive performance (working 
memory capacity, task-switching capacity, and execu-
tive control) and decreased regional GMV in CINP and 
CWAD patients. Similarly, Luerding et al (24) demon-
strated associations between reduced working memory 
performance and decreased GMV in the left dorsolat-
eral prefrontal cortex in fibromyalgia patients. 
Higher levels of pain catastrophizing and pain 
hypervigilance were correlated with decreased GMV 
in the precuneus, inferior frontal gyrus (pars orbitalis), 
medial orbitofrontal cortex, insula, thalamus, posterior 
cingulate cortex, and rostral middle frontal cortex in 
patients with CWAD. Our results are consistent with 
previous studies exploring associations between pain 
catastrophizing and GM morphology. For example, 
Hubbard et al (102) observed associations between 
higher pain catastrophizing and lower GMV in pain 
processing regions in migraine patients. 
Furthermore, increased local hyperalgesia, as re-
vealed by lower PPTs at the trapezius muscle in CWAD 
patients, was correlated with decreased GMV in the left 
postcentral cortex, which is a region involved in pain 
perception and processing nociceptive stimuli (103). Re-
cently, Niddam et al (96) demonstrated an association 
between decreased PPTs at the trapezius muscle (local 
hyperalgesia) and decreased GMV in the right middle 
frontal cortex in patients with chronic myofacial pain. 
Lastly, our study found that increased self-reported 
symptoms of CS were correlated with decreased GMV in 
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the left amygdala in CWAD. Interestingly, the amygdala 
is a key region involved in pain processing and cognitive 
factors of pain anticipation (104) and has a crucial role 
in negative emotions and pain-related memories (105). 
Limitations and Strengths 
With regard to interpretation of the present study 
results, the following limitations must be taken into 
account. First, the cross-sectional nature of this study 
implies that no conclusions about the causality of the 
observed relationships can be drawn. Second, the 
generalizability of the study results might be reduced 
because only women were included and only CWAD 
patients classified as WAD II A, B, or C were included; 
however, this results in less heterogeneity in the in-
cluded study sample, which is also a strength. 
Nonetheless, the present study also had several 
strengths. First, this study is the first to address the 
relationships between GMV alterations on one hand 
and self-reported and experimental features of cogni-
tion, pain, and CS on the other hand in CINP and CWAD 
patients. Second, all of the groups were comparable in 
age, body mass index, education level, smoking status, 
menstrual phase, medication use, neck pain duration, 
and frequency of neck pain (for the patient groups). 
In addition, the researchers anticipated sources of bias 
such as use of medications, caffeine, alcohol, and nico-
tine on the assessment days. A final strength is the use 
of FreeSurfer, which has some advantages over voxel-
based morphometry. 
Clinical Message 
Our results indicate that chronic pain in CWAD 
patients should be interpreted, at least in part, as a 
result of neural reorganization of the central nervous 
system (CNS), associated with alterations in GMV of re-
gions involved in various aspects of pain and cognitive 
processing. 
Importantly, increased cognitive deficits, maladapt-
ed pain cognitions, and CS symptoms were found to be 
associated with decreased GMV in regions implicated in 
processing cognition and pain in CWAD patients. There-
fore, it can be recommended that therapy approaches 
for CWAD should address the brain and take into ac-
count neuroplasticity of the CNS. Cognitive behavioral 
therapy can be advocated and has been demonstrated 
to reverse regional GMV decreases associated with 
reduced pain catastrophizing and decreased cognitive 
deficits in other chronic pain patients characterized by 
CS (106,107). 
In CINP patients, only cognitive deficits were relat-
ed to decreased regional GMV, and no GMV alterations 
or CS could be revealed. Accordingly, fewer indications 
are currently available for a role of brain alterations 
and CNS reorganization in the pathophysiology of CINP 
at a group level. Nevertheless, at the individual patient 
level, it is still possible that CNS mechanisms play a role, 
and subsequently, the therapeutic approach should 
be personalized for each specific patient regardless of 
diagnosis. 
Encouragingly, multiple studies have shown in 
other chronic pain conditions that decrease in GM 
morphology, including GMV, is at least partially re-
versible when underlying pain is adequately treated 
(96,108,109). These studies are clinically relevant as they 
suggest that at least some of the morphological GM 
changes must be a direct consequence of the presence 
of pain and related sequel and possibly the underlying 
mechanism is based on synaptic plasticity (92).
To summarize, the current study results pave the 
way for the development of novel and more effective 
treatment approaches for patients with chronic neck 
pain. 
Recommendations for Further Research
The exact underlying mechanisms responsible for 
decreased regional GMV in CWAD patients remain 
unclear. The potential underlying mechanisms for GMV 
changes include changes in synaptic density and den-
dritic spine structure, among others (110). It is possible 
that the observed GMV decrease reflects tissue shrink-
age, which can be caused by affected neural tissue or 
extracellular and microvascular volume without sub-
stantially impacting neuronal properties (111). Further 
research should investigate the underlying neurobio-
logical mechanisms of the observed GMV alterations. 
In addition, future research should investigate possible 
alterations in white matter microstructure in patients 
with CWAD compared to CINP. 
The regional GMV decrease can also be interpreted 
in the light of maladapted neuroplasticity (97). This 
is relevant when considering the dynamic features of 
GMV alterations associated with persistent pain. Neural 
reorganization can range from synaptic plasticity to 
changes in neural circuitry (e.g., long-term potentia-
tion, synaptic sprouting, neurogenesis (112), and glial 
reorganization).  
Whether these GMV changes are the consequence 
of pain or whether pre-existent alterations of these 
regions make patients more susceptible to the develop-
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ment of CWAD remains to be elucidated. Longitudinal 
research is warranted and research should unravel if 
therapy can re-shape the brain and diminish the associ-
ated burden in CWAD patients. Noteworthy, the cur-
rent study has investigated only one piece of the puzzle 
regarding possible brain alterations in patients with 
CINP and CWAD. Accordingly, future brain imaging 
research has to further disentangle possible structural 
and functional brain changes in patients with chronic 
neck pain.  
conclusion
The present innovative study provided evidence 
for decreased GMV in cortical regions associated with 
pain and cognitive processing in women with CWAD 
compared to women with CINP and healthy women. 
Additionally, in women with CWAD, decreased GMV in 
cognitive and pain processing regions was associated 
with increased cognitive deficits, maladapted pain cog-
nitions, self-perceived CS symptoms, and local hyperal-
gesia. In women with CINP, decreased GMV was only 
associated with increased cognitive deficits, but com-
pared with healthy controls no GMV alterations could 
be revealed. These findings indicate a possible negative 
mediating role of the trauma in patients with CWAD. 
The underlying neurobiological mechanisms of these 
GMV alterations remain to be elucidated and no con-
clusions about the causality of the observed relation-
ships can be drawn. Accordingly, longitudinal research 
is warranted to unravel whether these GMV alterations 
occur as a result of chronic pain or vice versa.  Based on 
the present study results, it can be recommended that 
therapy approaches for CWAD should take into account 
the role of CNS neuroplasticity. 
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Supplementary Table B. Non-significant differences in grey matter volume of  ROIs involved in processing of  cognition and pain in 
CWAD patients, CINP patients and healthy women.
Estimated means Tests of  between-Subjects Effects
Mean* Std. Error 95% Confidence Interval F-value (P-value)
Lower Bound Upper Bound
Caudal anterior cingulate volume (left hemisphere) (mm3)
HCON 2022.697 84.968 1853.504 2191.890
1.146 (0.323)CINP 1849.925 75.519 1699.546 2000.303
CWAD 1933.957 84.169 1766.356 2101.558
Caudal anterior cingulate volume (right hemisphere) (mm3)
HCON 2238.221 88.037 2062.916 2413.526
0.662 (0.519)CINP 2103.819 78.247 1948.008 2259.629
CWAD 2182.124 87.209 2008.469 2355.779
Rostral anterior cingulate volume (left hemisphere) (mm3)
HCON 2815.528 95.081 2626.197 3004.859
1.857 (0.163)CINP 2595.038 84.508 2426.761 2763.314
CWAD 2592.465 94.187 2404.916 2780.015
Rostral anterior cingulate volume (right hemisphere) (mm3)
HCON 2223.509 78.969 2066.262 2380.756
1.058 (0.352)CINP 2148.890 70.187 2009.129 2288.650
CWAD 2061.148 78.226 1905.381 2216.915
Posterior cingulate volume (right hemisphere) (mm3)
HCON 3239.293 87.813 3064.435 3414.151
1.755 (0.180)CINP 3080.014 78.048 2924.600 3235.427
CWAD 3012.570 86.987 2839.357 3185.782
Rostral middle frontal volume (left hemisphere) (mm3)
HCON 15797.621 340.979 15118.645 16476.597
1.027 (0.363)CINP 15447.520 303.061 14844.048 16050.992
CWAD 15105.454 337.771 14432.867 15778.042
Rostral middle frontal volume (right hemisphere) (mm3)
HCON 15021.037 343.129 14337.780 15704.294
0.347 (0.708)CINP 14776.898 304.972 14169.621 15384.174
CWAD 14618.770 339.900 13941.942 15295.598
Medial orbitofrontal volume (left hemispere) (mm3)
HCON 4624.112 108.906 4407.251 4840.973
2.305 (0.107)CINP 4540.005 96.796 4347.260 4732.750
CWAD 4307.561 107.882 4092.741 4522.381
Medial orbitofrontal volume (right hemispere) (mm3)
HCON 4786.377 97.557 4592.116 4980.637
1.228 (0.298)CINP 4583.517 86.708 4410.859 4756.175
CWAD 4701.462 96.639 4509.030 4893.895
Lateral orbitofrontal volume (left hemisphere) (mm3)
HCON 7556.569 150.887 7256.115 7857.023
1.161 (0.319)CINP 7396.945 134.108 7129.902 7663.988
CWAD 7230.979 149.467 6933.351 7528.606
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Estimated means Tests of  between-Subjects Effects
Mean* Std. Error 95% Confidence Interval F-value (P-value)
Lower Bound Upper Bound
Insula volume (left hemisphere) (mm3)
HCON 6650.029 135.783 6379.651 6920.407
1.807 (0.171)CINP 6619.807 120.683 6379.495 6860.118
CWAD 6326.050 134.505 6058.216 6593.884
Insula volume (right hemisphere) (mm3)
HCON 6759.804 131.606 6497.743 7021.865
1.419 (0.248)CINP 6677.191 116.971 6444.272 6910.110
CWAD 6458.759 130.368 6199.164 6718.355
Postcentral volume (left hemisphere) (mm3)
HCON 9350.764 227.937 8896.884 9804.645
0.590 (0.557)CINP 9683.044 202.590 9279.637 10086.452
CWAD 9517.861 225.792 9068.251 9967.471
Postcentral volume (right hemisphere) (mm3)
HCON 9045.141 267.322 8512.835 9577.447
0.028 (0.973)CINP 8984.258 237.595 8511.146 9457.370
CWAD 8958.659 264.807 8431.362 9485.957
Precuneus volume (left hemisphere) (mm3)
HCON 9579.739 220.170 9141.325 10018.153
1.011 (0.369)CINP 9593.422 195.686 9203.761 9983.083
CWAD 9214.218 218.098 8779.929 9648.506
Precuneus volume (right hemisphere) (mm3)
HCON 992.580 200.089 9530.152 10327.008
2.240 (0.113)CINP 10015.495 177.838 9661.373 10369.617
CWAD 9478.566 198.206 9083.887 9873.245
Pars Orbitalis volume (left hemisphere) (mm3)
HCON 2201.797 56.529 2089.233 2314.361
1.609 (0.207)CINP 2218.293 50.243 2118.247 2318.340
CWAD 2091.079 55.997 1979.574 2202.584
Pars Orbitalis volume (right hemisphere) (mm3)
HCON 2649.025 71.052 2507.542 2790.509
1.406 (0.251)CINP 2580.656 63.151 2454.906 2706.406
CWAD 2481.601 70.384 2341.449 2621.753
Supramarginal cortex volume (right hemisphere) (mm3)
HCON 10579.946 287.451 10007.558 11152.334
1.700 (0.190)CINP 10192.171 255.486 9683.434 10700.908
CWAD 9829.081 284.746 9262.079 10396.084
Superior parietal volume (left hemisphere) (mm3)
HCON 13092.699 301.360 12492.614 13692.784
1.212 (0.303)CINP 13000.016 267.848 12466.663 13533.370
CWAD 12486.401 298.525 11891.962 13080.839
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Estimated means Tests of  between-Subjects Effects
Mean* Std. Error 95% Confidence Interval F-value (P-value)
Lower Bound Upper Bound
Amygdala volume (left hemisphere) (mm3)
HCON 1502.540 33.352 1436.128 1568.952
2.428 (0.095)CINP 1601.342 29.643 1542.315 1660.369
CWAD 1555.476 33.038 1489.689 1621.263
Amygdala volume (right hemisphere) (mm3)
HCON 1464.975 29.053 1407.123 1522.827
1.652 (0.198)CINP 1535.188 25.822 1483.769 1586.607
CWAD 1514.461 28.780 1457.153 1571.768
Thalamus volume (left hemisphere) (mm3)
HCON 7818.711 170.216 7479.768 8157.655
1.043 (0.357)CINP 7792.152 151.288 7490.900 8093.404
CWAD 7511.332 168.615 7175.578 7847.087
Thalamus volume (right hemisphere) (mm3)
HCON 7046.965 117.792 6812.411 7281.518
1.947 (0.150)CINP 6999.345 104.693 6790.875 7207.816
CWAD 6745.843 116.683 6513.497 6978.189
*Covariates appearing in the model are evaluated at the following values: age = 33.630. HCON n = 25; CINP n = 31; CWAD n =25 
Abbreviations: HCON = healthy controls, CINP = chronic idiopathic neck pain, CWAD = chronic whiplash associated disorders, ROIs = regions 
of interest
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